Bioxyne Limited (ASX:BXN)

Market Cap	100.80M +4.7%
Revenue (ttm)	29.28M +203.7%
Net Income	4.90M
EPS	0.00
Shares Out	2.24B
PE Ratio	19.57
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,767,615
Average Volume	2,967,031
Open	0.0450
Previous Close	0.0450
Day's Range	0.0450 - 0.0460
52-Week Range	0.0190 - 0.0600
Beta	0.54
RSI	58.34
Earnings Date	Feb 25, 2026

About Bioxyne

Bioxyne Limited, together with its subsidiaries, manufactures and distributes therapeutic goods, and health and wellness products in Australia, the United States, the United Kingdom, Czechia, Switzerland, France, Germany, and Japan. It operates through Pharmaceutical Manufacture and Wholesale Supply of Novel Medicines, Cannabis, Psilocybin, and MDMA; Manufacture and Distribution (Wholesale, Online, and Retail) of Consumer Health and Novel Food Products; and Wholesale of Patented Probiotics segments. The company offers active pharmaceutical ingr...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1998
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: BXN